Clinical Trials Browser

Phase 1 × Solid Tumor × navitoclax × Clear all

NCT00888108 2012-05-22

Safety Profile, MTD, and PK Profile Studies of ABT-263 When Administered in Combination With Standard and Weekly Regimens of Docetaxel in Subjects With Cancer

Phase 1 Completed

Other solid neoplasm

Solid Tumor